Tobias B. Skillback

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Correction: Comorbidities predict institutionalization and mortality in biomarker-confirmed alzheimer's disease.

Correction: Comorbidities predict institutionalization and mortality in biomarker-confirmed alzheimer's disease.

Journal: Alzheimer's research & therapy

Published: May 21, 2026

Prevalence of high-risk plasma p-tau217 levels and 5-year transition of risk status in 70-year-olds.

Prevalence of high-risk plasma p-tau217 levels and 5-year transition of risk status in 70-year-olds.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: December 15, 2025

Utilization and Lifetime Costs of Formal Care for Alzheimer's Disease Dementia in Sweden.

Utilization and Lifetime Costs of Formal Care for Alzheimer's Disease Dementia in Sweden.

Journal: PharmacoEconomics

Published: September 14, 2025

The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer's Disease in Sweden.

The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer's Disease in Sweden.

Journal: PharmacoEconomics

Published: July 15, 2025

Frailty and prognosis of biomarker-confirmed Alzheimer's disease: a Swedish, register-based, retrospective cohort study.

Frailty and prognosis of biomarker-confirmed Alzheimer's disease: a Swedish, register-based, retrospective cohort study.

Journal: The lancet. Healthy longevity

Published: May 28, 2025

Cerebrospinal Fluid Biomarkers for Alzheimer Disease Among Patients With Dementia.

Cerebrospinal Fluid Biomarkers for Alzheimer Disease Among Patients With Dementia.

Journal: JAMA neurology

Published: April 28, 2025

Alcohol consumption and cerebrospinal fluid biomarkers for preclinical alzheimer's disease in a population-based sample of 70-year-olds.

Alcohol consumption and cerebrospinal fluid biomarkers for preclinical alzheimer's disease in a population-based sample of 70-year-olds.

Journal: Alzheimer's research & therapy

Published: April 04, 2025

Comorbidities predict institutionalization and mortality in biomarker-confirmed alzheimer's disease.

Comorbidities predict institutionalization and mortality in biomarker-confirmed alzheimer's disease.

Journal: Alzheimer's research & therapy

Published: March 26, 2025

Costs of Care in Relation to Alzheimer's Disease Severity in Sweden: A National Registry-Based Cohort Study.

Costs of Care in Relation to Alzheimer's Disease Severity in Sweden: A National Registry-Based Cohort Study.

Journal: PharmacoEconomics

Published: September 30, 2024

Proportion of Community-Dwelling Individuals Older Than 70 Years Eligible for Lecanemab Initiation: The Gothenburg H70 Birth Cohort Study.

Proportion of Community-Dwelling Individuals Older Than 70 Years Eligible for Lecanemab Initiation: The Gothenburg H70 Birth Cohort Study.

Journal: Neurology

Published: April 09, 2024

Subtle Differences in Cognition in 70-Year-Olds with Elevated Cerebrospinal Fluid Neurofilament Light and Neurogranin: A H70 Cross-Sectional Study.

Subtle Differences in Cognition in 70-Year-Olds with Elevated Cerebrospinal Fluid Neurofilament Light and Neurogranin: A H70 Cross-Sectional Study.

Journal: Journal of Alzheimer's disease : JAD

Published: January 09, 2023

Association of Chronic Kidney Disease With Plasma NfL and Other Biomarkers of Neurodegeneration: The H70 Birth Cohort Study in Gothenburg.

Association of Chronic Kidney Disease With Plasma NfL and Other Biomarkers of Neurodegeneration: The H70 Birth Cohort Study in Gothenburg.

Journal: Neurology

Published: December 30, 2022

Showing 1-12 of 37

Last Updated: 09/26/2026